Dr Gina Simone Wilson, MD ( MEDICAL DOCTO | |
340 9th St, Florence, OR 97439-9470 | |
(541) 902-1634 | |
(541) 902-9702 |
Full Name | Dr Gina Simone Wilson |
---|---|
Gender | Female |
Speciality | Obstetrics & Gynecology |
Location | 340 9th St, Florence, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679567788 | NPI | - | NPPES |
40235 | Other | TN | STATE HEALTH LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 40235 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Gina Simone Wilson, MD ( MEDICAL DOCTO 1115 Se 164th Ave Dept 358, Vancouver, WA 98683-8004 Ph: (541) 902-1634 | Dr Gina Simone Wilson, MD ( MEDICAL DOCTO 340 9th St, Florence, OR 97439-9470 Ph: (541) 902-1634 |
News Archive
"For years, John Finkenberg, an orthopedic surgeon in San Diego, sent patients who needed MRIs to outside imaging centers. But last year, he and his five partners bought their own million-dollar machine and now, he says, the doctors can work more closely with the technicians and give their patients immediate results" (Galewitz, 8/23).
BIOLASE Technology, Inc., the world's leading dental laser company, today reported operating results for the 2009 third quarter and nine months ended September 30, 2009.
Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses.
Marinomed Biotech AG, a globally operating biopharmaceutical company, announced today plans to initiate a Phase IV clinical trial with Carragelose (iota-carrageenan).
The COVID-19 pandemic was predicted to and has had a major impact on the essential HIV health services in the South East Asia Region (SEAR), putting at risk the benefits accrued over the last two decades. Apart from the risks posed by the virus to the individual health of people living with HIV (PLHIV), COVID-19 has disrupted essential services causing considerable delays in the delivery of medicines and other health commodities.
› Verified 4 days ago